Le Lézard
Classified in: Health

Parkhurst NuVision to Perform Highly Anticipated National Launch of New Permanent Contact Lens for Astigmatism


SAN ANTONIO, Sept. 21, 2018 /PRNewswire-PRWeb/ -- Parkhurst NuVision, a San Antonio, Texas-based vision correction facility, has been chosen to perform the highly anticipated national launch of a new permanent contact lens for myopia and astigmatism in one. Dr. Greg Parkhurst will be the first surgeon in the nation to offer the Visian toric ICL to his patients in November 2018. The Visian Toric ICL, a variant of Visian ICL technology created by STAAR Surgical, has been approved by the FDA and allows surgeons to treat astigmatism while simultaneously correcting vision.

"The Visian ICL represents a permanent contact lens that has been available for over a decade. The procedure has helped hundreds of thousands of patients enjoy life free from glasses or contacts. However, it has not been a particularly good option for patients with significant astigmatism...until now," says Greg Parkhurst, MD, a leading San Antonio LASIK specialist and one of the most experienced Visian surgeons in America. "With the FDA-approved Visian Toric ICL, surgeons will now be able to use this excellent procedure to treat moderate and even high astigmatism during the vision correction process."

The Visian technology is similar to LASIK in that it is a long-term vision correction solution. During LASIK, the shape of the eye's surface (cornea) is changed to correct the patient's vision. The Visian is made of a collagen co-polymer, similar to collagen in the rest of the body, so it is biocompatible. The permanent contact lens is placed just beneath the surface of the eye to achieve vision correction.

"The FDA's approval of STAAR Surgical's Visian Toric ICL in the U.S. provides an intuitive treatment option for myopic patients with astigmatism in search of visual freedom," adds STAAR Surgical's President and CEO Caren Mason. "We are thrilled to be offering this lens in the United States, and look forward to officially making the Visian Toric ICL available to U.S. surgeons for their patients."

As a Visian ICL surgery center, Parkhurst NuVision serves patients in San Antonio, Austin, New Braunfels, Eagle Pass, Laredo, Corpus Christi, Uvalde and other Texas communities, as well as patients from across the country and even around the world. Further, STAAR Surgical has added its seal of approval to state Dr. Parkhurst is the most experienced Visian ICL surgeon in the Lone Star State, citing the fact that surgeons have traveled to San Antonio from countries in Europe, Asia and South America to learn Visian ICL treatment methods from Dr. Parkhurst himself.

"For several years now, ICL surgery has been an excellent choice for our San Antonio patients seeking ultra-high-definition vision correction," says Parkhurst NuVision Clinic Director Roberto "Bobby" Saenz, O.D., M.S., F.A.A.O. "We waited until we moved back home to San Antonio, so that Dr. Parkhurst could perform ICL surgery on my wife. She loves it, being able to wake up in the middle of the night to get our 1 year old daughter without having to look for her glasses is awesome."

Dr. Parkhurst's wife has had ICL as well. "With so many people across the country who have been waiting for access to such a life-changing technology, we are excited to share the good news with the many people on our Toric ICL waiting list, and offer them the procedure right here in San Antonio."

Parkhurst NuVision is located at 9725 Datapoint Drive Suite 200 in San Antonio and can be reached by calling (210) 615-9358. For more information visit http://www.ParkhurstNuVision.com.

 

SOURCE Parkhurst NuVision


These press releases may also interest you

at 09:40
RootPath, a synthetic biology company that elevates the throughput of gene function interrogation by orders of magnitude, today announced a new publication in Nature Biotechnology detailing research that demonstrates the power of the company's novel...

at 09:40
An automated tool that improves outbreak detection for hundreds of pathogens successfully served as an early warning system to find and respond to potential hospital outbreaks, as reported today in NEJM Evidence. A Trial of Automated Outbreak...

at 09:35
As the nation continues to grapple with a youth mental health crisis, the Women's Sports Foundation (WSF) - one of the first organizations to recognize the powerful connection between sports, equity, and society - released its latest research...

at 09:34
To investigate the use of advanced touch simulation for improving accessibility to digital information, the U.S. Department of Health and Human Services, National Institutes of Health, and National Eye Institute have awarded a Phase 1 Small Business...

at 09:32
Premier Healthcare Holdings, Inc. (PHHI), a private company, announced it has named healthcare industry veteran Buffy Stultz White as CEO to lead the next phase of growth....

at 09:30
Thermedical®, a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilizing Pulsed Field Ablation (PFA) therapy in combination with its SERF Ablation System and...



News published on and distributed by: